Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft models

BACKGROUND: Few chemotherapies are available for neuroendocrine tumors, especially for highly malignant neuroendocrine cancers. The third-generation oncolytic herpes simplex virus type 1 (HSV-1) T-01 selectively replicates in tumor cells and shows cytotoxicity against tumor cells without damaging su...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Matsushima, Hideyuki, Kaibori, Masaki, Hatta, Masahiko, Ishizaki, Morihiko, Nakatake, Richi, Okumura, Tadayoshi, Yoshii, Kengo, Todo, Tomoki
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2019
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935252/
https://ncbi.nlm.nih.gov/pubmed/31903171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27391
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki